Global Epinephrine Market Insights, Forecast to 2025
Epinephrine, also known as adrenalin or adrenaline, is a hormone, neurotransmitter and medication. Epinephrine is normally produced by both the adrenal glands and certain neurons. It plays an important role in the fight-or-flight response by increasing blood flow to muscles, output of the heart, pupil dilation, and blood sugar. It does this by its effects on alpha and beta receptors. It is found in many animals and some one-cell organisms. Jokichi Takamine first isolated epinephrine in 1901.
United States has the largest global export quantity and manufacturers in Epinephrine market, while the Europe is the second sales volume market for Epinephrine in 2017.
In the industry, Mylan Inc profits most in 2016 and recent years, while Impax and ALK Abello ranked 2 and 3.The market share of them is 52.75%, 4.37% and 2.64% in 2017.The gap of market share is keep on enlarged due to different strategy.
Nowadays, there are three mainly types of Epinephrine, including Epinephrine Auto-injector, Epinephrine Prefilled Syringe and Combination Epinephrine Products. And Epinephrine Auto-injector is the main type for Epinephrine, and the Epinephrine Auto-injector reached a sales value of approximately 1430.61 M USD in 2017, with 63.69% of global sales value.
Epinephrine technology is much mature now, and new enterprises can not surpass existing famous brands on reputation or design in the short term. So, the study group recommends the new entrants need to be considered carefully before enter into this field.
The global Epinephrine market is valued at 2250 million US$ in 2018 and will reach 3900 million US$ by the end of 2025, growing at a CAGR of 7.1% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Epinephrine market based on company, product type, end user and key regions.
This report studies the global market size of Epinephrine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Epinephrine in these regions.
This research report categorizes the global Epinephrine market by top players/brands, region, type and end user. This report also studies the global Epinephrine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Mylan Inc
Impax
ALK Abello
Lincoln Medical Ltd
Pfizer
Amphastar
Emerade
Grand Pharma
Harvest Pharmaceuticals
Merit Pharmaceutical
Tianjin Jinyao Group
Market size by Product
Epinephrine Auto-injector
Epinephrine Prefilled Syringe
Combination Epinephrine Products
Market size by End User
Anaphylaxis
Cardiac Arrest
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Epinephrine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Epinephrine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Epinephrine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Epinephrine submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Epinephrine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Epinephrine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
United States has the largest global export quantity and manufacturers in Epinephrine market, while the Europe is the second sales volume market for Epinephrine in 2017.
In the industry, Mylan Inc profits most in 2016 and recent years, while Impax and ALK Abello ranked 2 and 3.The market share of them is 52.75%, 4.37% and 2.64% in 2017.The gap of market share is keep on enlarged due to different strategy.
Nowadays, there are three mainly types of Epinephrine, including Epinephrine Auto-injector, Epinephrine Prefilled Syringe and Combination Epinephrine Products. And Epinephrine Auto-injector is the main type for Epinephrine, and the Epinephrine Auto-injector reached a sales value of approximately 1430.61 M USD in 2017, with 63.69% of global sales value.
Epinephrine technology is much mature now, and new enterprises can not surpass existing famous brands on reputation or design in the short term. So, the study group recommends the new entrants need to be considered carefully before enter into this field.
The global Epinephrine market is valued at 2250 million US$ in 2018 and will reach 3900 million US$ by the end of 2025, growing at a CAGR of 7.1% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Epinephrine market based on company, product type, end user and key regions.
This report studies the global market size of Epinephrine in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Epinephrine in these regions.
This research report categorizes the global Epinephrine market by top players/brands, region, type and end user. This report also studies the global Epinephrine market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.
The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Mylan Inc
Impax
ALK Abello
Lincoln Medical Ltd
Pfizer
Amphastar
Emerade
Grand Pharma
Harvest Pharmaceuticals
Merit Pharmaceutical
Tianjin Jinyao Group
Market size by Product
Epinephrine Auto-injector
Epinephrine Prefilled Syringe
Combination Epinephrine Products
Market size by End User
Anaphylaxis
Cardiac Arrest
Others
Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa
The study objectives of this report are:
To study and analyze the global Epinephrine market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Epinephrine market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Epinephrine companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Epinephrine submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
In this study, the years considered to estimate the market size of Epinephrine are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Epinephrine market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.
Please Select a Format
